DarioHealth Corp.

15.33-0.42 (-2.67%)
Oct 28, 4:00:01 PM EDT · NasdaqCM · DRIO · USD

Upcoming Earnings

Report date
Nov 6, 2025 (in 8 days)

Key Stats

Market Cap
103.76M
P/E (TTM)
-
Basic EPS (TTM)
-13.40
Dividend Yield
0%

Recent Filings

About

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

CEO
Mr. Erez Raphael
IPO
3/14/2016
Employees
196
Sector
Healthcare
Industry
Health Information Services